{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:16:34Z","timestamp":1782436594309,"version":"3.54.5"},"reference-count":158,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,1,2]],"date-time":"2022-01-02T00:00:00Z","timestamp":1641081600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Sumitomo Chemical Company, Ltd."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Toxicology"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/10408444.2022.2035316","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T15:19:05Z","timestamp":1647011945000},"page":"1-31","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of the human hazard of the liver and lung tumors in mice treated with permethrin based on mode of action"],"prefix":"10.1080","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-1049","authenticated-orcid":false,"given":"Tomoya","family":"Yamada","sequence":"first","affiliation":[{"name":"Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Lake","sequence":"additional","affiliation":[{"name":"School of Biosciences and Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5047-0962","authenticated-orcid":false,"given":"Samuel M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-803809-3.00006-3"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2013.835785"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1080\/01926230701347330"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/7.6.433"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1002\/tcm.1770140105"},{"key":"CIT0006","unstructured":"Barton S, Robinson S, Martin T. 2000. Permethrin technical 100 week carcinogenicity\/reversibility study in mice with administration by the diet: Lab Project Number: 452695: A954264. Unpublished study prepared by Inveresk Research."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/10408444.2018.1439449"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045259"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1080\/10408440600977677"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1080\/10408440701749421"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1998.8442"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/51.2.300"},{"issue":"1","key":"CIT0013","first-page":"74","volume":"47","author":"Buckpitt A","year":"1995","journal-title":"Mol Pharmacol"},{"key":"CIT0014","unstructured":"Cal.EPA. 1994. Permethrin (permethrin tick repellent), risk characterization document, medical toxicology and worker health and safety branches. Sacramento (CA): Department of Pesticide Regulation, California Environmental Protection Agency; [accessed 2021 Nov 25]. https:\/\/www.cdpr.ca.gov\/docs\/risk\/rcd\/permet_s3.pdf"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2008.09.017"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/44.1.46"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4274(98)00246-X"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.1997.1163"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0322"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1080\/713608371"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfh073"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310363813"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfq365"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1080\/10937404.2020.1763879"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2013.835784"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-017-2094-7"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2009.07.002"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2018.02.010"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4834-3"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.1999.1296"},{"key":"#cr-split#-CIT0031.1","unstructured":"ECHA. 2017. Guidance on the application of the CLP criteria, Guidance to regulation (EC) No 1272\/2008 on classification, labelling and packaging (CLP) of substances and mixtures, version 5.0"},{"key":"#cr-split#-CIT0031.2","unstructured":"[accessed 2021 Nov 25]. https:\/\/echa.europa.eu\/documents\/10162\/23036412\/clp_en.pdf\/58b5dc6d-ac2a-4910-9702-e9e1f5051cc5"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2013.835786"},{"key":"CIT0033","volume-title":"Analysis of physical observations, twenty-four month oral carcinogenicity study of FMC 33297 in mice","author":"Ellison T.","year":"1979"},{"issue":"1","key":"CIT0034","first-page":"4","volume":"56","author":"Farber E","year":"1987","journal-title":"Lab Invest"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-016-1886-5"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfab067"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfab068"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90474-J"},{"key":"#cr-split#-CIT0039.1","unstructured":"Giknis MLA, Clifford CB. 2005. Spontaneous neoplastic lesions in the Crl:CD-1(ICR) mouse in control groups from 18 month to 2 year studies. Charles River Laboratories"},{"key":"#cr-split#-CIT0039.2","unstructured":"[accessed 2021 Nov 25]. https:\/\/www.criver.com\/sites\/default\/files\/resources\/SpontaneousNeoplasticLesionsintheCrlCD-1ICRMouseinControlGroupsfrom18Monthto2YearStudies%E2%80%94March2005.pdf"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1080\/019262301753385979"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2007.09.030"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1997.2312"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(01)00236-8"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-483X(01)00488-7"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1080\/01926230601132063"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1177\/0192623389017004114"},{"key":"CIT0047","first-page":"119","volume-title":"Pathology of the mouse: reference and atlas","author":"Harada T","year":"1999","edition":"1"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-0590(83)80148-1"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh285"},{"key":"CIT0150","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(01)00639-6"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1080\/10408444.2020.1841732"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfj001"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.9193247"},{"key":"CIT0053","unstructured":"IARC. 1987. IARC Monographs on the evaluation of the carcinogenic risks to humansIs. Vol. 1 to 42. Supplement 7, Isonicotinic acid hydrazide (isoniazid). Lyon: IARC Press; p. 227\u2013229; [accessed 2021 Nov 25]. https:\/\/monographs.iarc.who.int\/wp-content\/uploads\/2018\/06\/Suppl7.pdf"},{"key":"CIT0054","unstructured":"IARC. 1996a. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 66. Clofibrate. Lyon: IARC Press; p. 391\u2013426; [accessed 2021 Nov 25]. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Some-Pharmaceutical-Drugs-1996"},{"key":"CIT0055","unstructured":"IARC. 1996b. IARC Monographs on the evaluation of carcinogenic risks to humans. Vol. 66. Gemfibrozil. Lyon: IARC Press; p. 427\u2013444; [accessed 2021 Nov 25]. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Some-Pharmaceutical-Drugs-1996"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(88)90156-X"},{"key":"CIT0057","unstructured":"JMPR. 1999. Permethrin, toxicological evaluations, pesticide residues in food. Joint meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group; [accessed 2021 Nov 25]. https:\/\/inchem.org\/documents\/jmpr\/jmpmono\/v99pr07.htm"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.3109\/01902148709062841"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1080\/713608372"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfz012"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfaa017"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2001.1527"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1080\/00498250903098184"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1039\/c8tx00008e"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2018.1555587"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.6.2043"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.6.3012"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1515\/DMDI.2009.24.2-4.229"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1002\/ar.1092390107"},{"key":"CIT0070","first-page":"19","volume-title":"Statistics in the pharmacutical industry","author":"Lin KK","year":"1994","edition":"2"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1136\/thx.39.11.844"},{"issue":"3","key":"CIT0072","first-page":"327","volume":"27","author":"Madan A","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg065"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-71617-1_2"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1293\/tox.22.11"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310373778"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1080\/02772248.2017.1401627"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(92)90098-D"},{"issue":"2","key":"CIT0079","first-page":"539","volume":"61","author":"McDowell EM","year":"1978","journal-title":"J Natl Cancer Inst"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.3109\/10408440903384717"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2019.02.017"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1080\/713608373"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2949"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2984"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.11.033"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3376"},{"key":"CIT0087","volume-title":"Guidance document 116 on the Conduct and design of chronic toxicity and carcinogenicity studies, supporting test guidelines 451, 452 and 453","author":"OECD","year":"2012","edition":"2"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-019-02602-7"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfab103"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23277-8"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2007.08.033"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1966.39"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/18.11.2029"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.11.1989"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.3109\/01902148009069646"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.3109\/01902148009069644"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-404577-4.00007-2"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.09.009"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/45.1.1"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1177\/0192623318809304"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(88)90285-0"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1177\/0192623309353423"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.09.002"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfn025"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.11318"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfn244"},{"issue":"2","key":"CIT0107","first-page":"839","volume":"43","author":"Schulte-Hermann R","year":"1983","journal-title":"Cancer Res"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1080\/10408440591007133"},{"issue":"2","key":"CIT0109","first-page":"510","volume":"296","author":"Shultz MA","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.17.2.f138"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1002\/aja.1001550103"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2001.1493"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2012.09.015"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfs127"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfw168"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-018-2308-7"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1177\/0192623314544378"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1186\/s42826-019-0032-y"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1177\/0192623310386499"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1293\/tox.25.189"},{"key":"CIT0121","first-page":"82","volume-title":"Pathology and genetics of tumours of the lung, pleura, thymus and heart","author":"Travis WD","year":"2004"},{"key":"#cr-split#-CIT0122.1","unstructured":"US.EPA. 1988. Memorandum. 52 Page(s). Esther Rinde. Toxicology Branch I. Peer Review of Permethrin. Registration Data info removed from pages 9-15, US. EPA. Attachment(s) Following: October 14, 1988. Memorandum. John Doherty. Toxicology Branch I. Peer Review of Permethrin. Addendum: Historical control data for lung & liver tumors for the CD-1 mouse strain compiled by the Bio\/Dynamics Laboratory for studies terminating in 1979 to 1982"},{"key":"#cr-split#-CIT0122.2","unstructured":"[accessed 2022 Jan 19]. https:\/\/archive.epa.gov\/pesticides\/chemicalsearch\/chemical\/foia\/web\/pdf\/109701\/109701-153.pdf"},{"key":"#cr-split#-CIT0123.1","unstructured":"US.EPA. 1994. PRN 94-5: requests for re-considerations of carcinogenicity peer review decisions based on changes in pathology diagnoses"},{"key":"#cr-split#-CIT0123.2","unstructured":"[accessed 2022 Jan 19]. https:\/\/www.epa.gov\/pesticide-registration\/prn-94-5-requests-re-considerations-carcinogenicity-peer-review-decisions#policy"},{"key":"#cr-split#-CIT0124.1","unstructured":"US.EPA. 2000. Data evaluation record: Permethrin\/109701. Study type: carcinogenicity - mouse (OPPTS 870.4200b\/OECD 451). MRID 45597105 (Main Study), 45597104"},{"key":"#cr-split#-CIT0124.2","unstructured":"[accessed 2022 Jan 19]. https:\/\/www3.epa.gov\/pesticides\/chem_search\/cleared_reviews\/csr_PC-109701_undated_a.pdf"},{"key":"#cr-split#-CIT0125.1","unstructured":"US.EPA. 2002. Memorandum. Permethrin: Report of the Cancer Assessment Review Committee (Third Evaluation). Health Effects Division, Office of Pesticides Program, US. EPA, TXR No. 0051220"},{"key":"#cr-split#-CIT0125.2","unstructured":"[accessed 2022 Jan 19]. https:\/\/www3.epa.gov\/pesticides\/chem_search\/cleared_reviews\/csr_PC-109701_23-Oct-02_a.pdf"},{"key":"CIT0126","unstructured":"US.EPA. 2003. Memorandum. Cypermethrin and Zeta-cypermethrin \u2013 5th Report of the Hazard Identification Assessment Review Committee. TXR NO. 0051578."},{"key":"CIT0127","unstructured":"US.EPA. 2005a. Guidelines for carcinogen risk assessment. Risk Assessment Forum, Washington, DC. EPA\/639\/P-03\/001F; [accessed 2021 Nov 25]. https:\/\/www3.epa.gov\/airtoxics\/cancer_guidelines_final_3-25-05.pdf"},{"key":"CIT0128","unstructured":"US.EPA. 2005b. Memorandum. Flonicamid: Report of the Cancer Assessment Review Committee, PC Cord: 128016. Health Effects Division, Office of Pesticides Program, US. EPA, TXR No.0052013; [accessed 2021 Nov 25]. https:\/\/archive.epa.gov\/pesticides\/chemicalsearch\/chemical\/foia\/web\/pdf\/128016\/128016-2005-02-24a.pdf"},{"key":"#cr-split#-CIT0129.1","unstructured":"US.EPA. 2009. Permethrin Facts. EPA document No. 738-F-09-001"},{"key":"#cr-split#-CIT0129.2","unstructured":"[accessed 2021 Nov 25]. https:\/\/www3.epa.gov\/pesticides\/chem_search\/reg_actions\/reregistration\/fs_PC-109701_1-Aug-09.pdf"},{"key":"CIT0130","unstructured":"US.EPA. 2020a. Memorandum. Permethrin. Report of the Cancer Assessment Review Committee (Fourth Evaluation). PC Cord: 109701. Health Effects Division, Office of Pesticides Program, US. EPA. TXR No. 0057953; [accessed 2022 Feb 15]. https:\/\/www.regulations.gov\/document\/EPA-HQ-OPP-2011-0039-0124"},{"key":"CIT0131","unstructured":"US.EPA. 2020b. Memorandum. Permethrin: Human Health Risk Assessment for New Use on \u201cFruit, Small, Vine Climbing, Except Fuzzy Kiwifruit, Subgroup 13-07F\u201d; Multiple Crop Group Conversions\/Expansions; and the Establishment of a Tolerance without a U.S. Registration for Tea, AND the Revised Draft Risk Assessment (DRA) for Registration Review; [accessed 2021 Nov 25]. https:\/\/www.regulations.gov\/document\/EPA-HQ-OPP-2011-0039-0130"},{"key":"CIT0132","unstructured":"US.FDA. 2001. Center for Drug Evaluation and Research, Guidance for Industry: Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals; [accessed 2021 Nov 25]. https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm079272.pdf"},{"key":"CIT0133","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfy050"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.21.1.3630"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfh237"},{"key":"CIT0136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043008"},{"key":"CIT0137","volume-title":"Guidance for national tuberculosis programmes on the management of tuberculosis in children","author":"WHO","year":"2014","edition":"2"},{"key":"#cr-split#-CIT0138.1","unstructured":"WHO. 2019. World Health Organization (WHO) specifications and evaluations for public health pesticides, Permethrin (40:60 cis:trans isomer ratio)"},{"key":"#cr-split#-CIT0138.2","unstructured":"[accessed 2021 Nov 25]. https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/vcp-documents\/WHOVC-SP_Permethrin%20%2840%2060%20cis%20trans%20isomer%20ratio%29_2019.pdf"},{"key":"CIT0139","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(97)00229-2"},{"key":"CIT0140","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.01.021"},{"key":"CIT0141","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/8.12.1889"},{"key":"CIT0142","doi-asserted-by":"publisher","DOI":"10.3109\/14653240903313974"},{"key":"CIT0143","doi-asserted-by":"publisher","DOI":"10.1177\/0192623315576005"},{"key":"CIT0144","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfx066"},{"key":"CIT0145","doi-asserted-by":"publisher","DOI":"10.1039\/c7tx00288b"},{"key":"CIT0146","doi-asserted-by":"publisher","DOI":"10.1293\/tox.2021-0027"},{"key":"CIT0147","doi-asserted-by":"publisher","DOI":"10.1080\/10408444.2021.1939654"},{"key":"CIT0148","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm206"},{"key":"CIT0149","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.8.8.8181666"}],"container-title":["Critical Reviews in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408444.2022.2035316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T09:57:32Z","timestamp":1652867852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408444.2022.2035316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,2]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/10408444.2022.2035316"],"URL":"https:\/\/doi.org\/10.1080\/10408444.2022.2035316","relation":{},"ISSN":["1040-8444","1547-6898"],"issn-type":[{"value":"1040-8444","type":"print"},{"value":"1547-6898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itxc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}